GB2230953B - Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease - Google Patents

Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease

Info

Publication number
GB2230953B
GB2230953B GB9010190A GB9010190A GB2230953B GB 2230953 B GB2230953 B GB 2230953B GB 9010190 A GB9010190 A GB 9010190A GB 9010190 A GB9010190 A GB 9010190A GB 2230953 B GB2230953 B GB 2230953B
Authority
GB
United Kingdom
Prior art keywords
carnitine
treatment
compositions containing
acyl derivative
protozoal disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9010190A
Other languages
English (en)
Other versions
GB9010190D0 (en
GB2230953A (en
Inventor
Mario Manganaro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Publication of GB9010190D0 publication Critical patent/GB9010190D0/en
Publication of GB2230953A publication Critical patent/GB2230953A/en
Application granted granted Critical
Publication of GB2230953B publication Critical patent/GB2230953B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9010190A 1989-05-05 1990-05-04 Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease Expired - Fee Related GB2230953B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8947916A IT1231944B (it) 1989-05-05 1989-05-05 Composizione farmaceutica per il trattamento di protozoosi, particolarmente della tripasonomiasi comprendente d-carnitina o un alcanoilderivato della d-carnitina

Publications (3)

Publication Number Publication Date
GB9010190D0 GB9010190D0 (en) 1990-06-27
GB2230953A GB2230953A (en) 1990-11-07
GB2230953B true GB2230953B (en) 1993-03-24

Family

ID=11263328

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9010190A Expired - Fee Related GB2230953B (en) 1989-05-05 1990-05-04 Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease

Country Status (5)

Country Link
AP (1) AP137A (it)
GB (1) GB2230953B (it)
IT (1) IT1231944B (it)
OA (1) OA09832A (it)
ZA (1) ZA903352B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254136B (it) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.
IT1254135B (it) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antibatterica.

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474424A (en) * 1973-09-26 1977-05-25 Kawashima Y Pharmaceutical composition for treating diabetic ketoacidosis
GB2013495A (en) * 1978-02-03 1979-08-15 Sigma Tau Ind Farmaceuti Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
GB2013496A (en) * 1978-02-03 1979-08-15 Sigma Tau Ind Farmaceuti Treating hyperlipoproteinaemias and hyperlipidaemias
GB2021410A (en) * 1978-05-25 1979-12-05 Cavazza Claudio Pharmaceutical compositions containing carnitine
DE2911670A1 (de) * 1979-02-12 1980-08-14 Sigma Tau Ind Farmaceuti Arzneimittel zur therapeutischen behandlung von peripheren vaskularen erkrankungen
JPS5661314A (en) * 1979-10-24 1981-05-26 Otsuka Pharmaceut Factory Inc Preventive against side-effect for dialytic patient
JPS57126420A (en) * 1981-01-26 1982-08-06 Eiji Murakami Drug for digestive organ
JPS5888312A (ja) * 1981-11-06 1983-05-26 シグマ―タウ・インダストリエ・ファルマシゥティシェ・リウニテ・ソシエタ・ペル・アチオーニ カルニチンまたは低級アシルカルニチンからなる静脈疾患治療剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1191945B (it) * 1986-06-04 1988-03-31 Avantgarde Spa N-alchilammidi della d(+)-carnitina dotate di attivita' antibatterica,procedimento per la loro preparazione e composizioni farmaceutiche e cosmetiche che le contengono
CH676930A5 (it) * 1988-05-26 1991-03-28 Bernardini Attilio

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474424A (en) * 1973-09-26 1977-05-25 Kawashima Y Pharmaceutical composition for treating diabetic ketoacidosis
GB2013495A (en) * 1978-02-03 1979-08-15 Sigma Tau Ind Farmaceuti Therapeutic method for the treatment of hyperlipodaemias and hyperlipoproteinaemias
GB2013496A (en) * 1978-02-03 1979-08-15 Sigma Tau Ind Farmaceuti Treating hyperlipoproteinaemias and hyperlipidaemias
GB2021410A (en) * 1978-05-25 1979-12-05 Cavazza Claudio Pharmaceutical compositions containing carnitine
GB2021414A (en) * 1978-05-25 1979-12-05 Cavazza Claudio Pharmaceutical compositions containing an acyl-carnitine
DE2911670A1 (de) * 1979-02-12 1980-08-14 Sigma Tau Ind Farmaceuti Arzneimittel zur therapeutischen behandlung von peripheren vaskularen erkrankungen
JPS5661314A (en) * 1979-10-24 1981-05-26 Otsuka Pharmaceut Factory Inc Preventive against side-effect for dialytic patient
JPS57126420A (en) * 1981-01-26 1982-08-06 Eiji Murakami Drug for digestive organ
JPS5888312A (ja) * 1981-11-06 1983-05-26 シグマ―タウ・インダストリエ・ファルマシゥティシェ・リウニテ・ソシエタ・ペル・アチオーニ カルニチンまたは低級アシルカルニチンからなる静脈疾患治療剤

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Chemical Abstracts 94(6):36351v; & DE-A-2911670 *
Chemical Abstracts 95(16):138625a; & JP-A-56 061 314 *
Chemical Abstracts 97(22):188290z; & JP-A-57 126 420 *
Chemical Abstracts 99(10):76891f; & JP-A-58 088 312 *

Also Published As

Publication number Publication date
GB9010190D0 (en) 1990-06-27
GB2230953A (en) 1990-11-07
AP9000180A0 (en) 1990-07-31
IT1231944B (it) 1992-01-16
OA09832A (en) 1994-04-15
ZA903352B (en) 1991-02-27
AP137A (en) 1991-08-05
IT8947916A0 (it) 1989-05-05

Similar Documents

Publication Publication Date Title
GR1002052B (en) Alimentary influence agent of the nerves coming from the brain
HU896444D0 (en) Process for the preparation of pharmaceutical compositions
EP0472075A3 (en) Process for the preparation of polysaccharides
EG20296A (en) Process for the preparation of azamacrocyclic acyl aminophosphonate ester derivatives
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
IL104132A0 (en) Compositions for the treatment of mammalian diseases
HU906211D0 (en) Process for the preparation of anthelminthics
GB2230953B (en) Compositions containing d-carnitine or an acyl derivative for the treatment of protozoal disease
HU904564D0 (en) Process for the preparation of solid medical products
EP0523534A3 (en) Process for the preparation of polyenes
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
IL96455A0 (en) Pharmaceutical compositions for the treatment of hsv
IL97512A0 (en) Process for the preparation of 1-hydroxyalkyl-5-nitro-imidazoles
EP0444460A3 (en) Process for the preparation of acrolin
IL86147A (en) Pharmaceutical compositions comprising 3-amino-4-ethylthio-quinoline derivative and process for the preparation of this compound
EP0412938A3 (en) System for the treatment of contactlenses
GB9016062D0 (en) Process for the preparation of acrylates
EP0459242A3 (en) Process for the preparation of phenolethers
IL98876A0 (en) Process for the preparation of n-alkylsulfonyl aminosulfonylureas
EP0460690A3 (en) Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
HU896301D0 (en) Process for the preparation of resisant food-products containing inulin
OA09641A (en) Compositions for the treatment of leishmaniasis
GB9205920D0 (en) Process for the preparation of pyrethroide derivatives
EP0467308A3 (en) Process for the preparation of 2-hydroxy-3-halogen-5-nitropyridines

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19970504